Evaluation of bacterial contents, package labelling and antimicrobial activity of some commercial probiotic products available in local market

Year 2022, Volume: 26 Issue: 3, 502 - 509, 28.06.2025

Zahraa Amer Hashim

Abstract

The global use of probiotic products has been increasing steadily. These products are therapeutically
intended for the prevention or treatment of various diseases. Commercial probiotic products are diverse, however no
local or international regulations are applied to control the quality of these products. Many international studies have
shown a scarcity of probiotic products that comply with the international guidelines. In Iraq, there are no previous
studies that have looked at probiotic products from this scope. Therefore, the aim of this study was to assess whether
the bacterial contents and package labels of some commercial probiotic products were correct. In addition, the study
aimed to evaluate the in vitro antimicrobial activity of the isolated probiotics. Eighteen probiotic products were
purchased from local community pharmacies within 7-month period. Bacterial contents were counted using culture and
count method. Packages’ labels were checked for contents and spelling accuracy. Antimicrobial activity was performed
using conventional well-diffusion assay. Half of the eighteen products purchased from local pharmacies, did not fulfill
the taxonomy and nomenclature of bacteria. 7 products (38.8%) demonstrated positive growth on culture media and
none of them matched the labelled bacterial counts on their packages. Of these 7 products, it has been found that the 24
h-spent culture of product-1 was the only one that demonstrated the ability to inhibit the growth of Staphylococcus aureus
in vitro. These findings necessitate the need for quality and efficacy control of these fairly expensive products. The effect
of packaging and storage on the efficacy of these commercial products should also be taken into consideration.

Keywords

Antimicrobial effect , bacterial count , label accuracy , probiotics , quality control , Saccharomyces boulardii

References

• [1] Food and Agriculture Organization of the United Nations (FAO)/World Health Organization (WHO). Probiotics in food: health and nutritional properties and guidelines for evaluation. Food and Nutrition Paper. 2006; 85: 1-56. https://www.fao.org/3/a0512e/a0512e.pdf.
• [2]Wassenaar TM, Klein G. Safety aspects and implications of regulation of probiotic bacteria in food and food supplements. J Food Prot. 2008; 71(8): 1734-1741. [crossref]
• [3] Mattia A, Merker R. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification. Clin Infect Dis. 2008; 1(46) Suppl 2: 115-118; discussion 144-151. [crossref]
• [4] McFarland LV. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open. 2014; 4(8): e005047. [crossref]
• [5] FAO/WHO (2001) Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation, Córdoba, Argentina. https://www.fao.org/publications/card/en/c/7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6/
• [6] Sharp MD, McMahon DJ, Broadbent JR. Comparative evaluation of yogurt and low-fat cheddar cheese as delivery media for probiotic Lactobacillus casei. J Food Sci. 2008; 73(7): M375-377. [crossref]
• [7] Drago L, Rodighiero V, Celeste T, Rovetto L, De Vecchi E. Microbiological evaluation of commercial probiotic products available in the USA in 2009. J Chemother. 2010; 22(6): 373-377. [crossref]
• [8] Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J. 2011; 52(1): 43-46.
• [9] Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol. 2003; 81(1): 1-10. [crossref]
• [10] Elliot E, Teversham K. An evaluation of nine probiotics available in South Africa, August 2003. S Afr Med J. 2004; 94(2): 121-124.
• [11] Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol. 2003; 82(1): 59-70. [crossref]
• [12] Aureli P, Fiore A, Scalfaro C, Casale M, Franciosa G. National survey outcomes on commercial probiotic food supplements in Italy. Int J Food Microbiology. 2010; 137(2-3): 265-273. [crossref]
• [13] CRONE PB. The counting of surface colonies of bacteria. J Hyg (Lond). 1948; 46(4): 426-430. [crossref]
• [14] Tagg JR, McGiven AR. Assay system for bacteriocins. Appl Microbiol. 1971; 21(5): 943. [crossref]
• [15] Gajdács, M. Taxonomy and Nomenclature of Bacteria With Clinical and Scientific Importance: Current Concepts for Pharmacists and Pharmaceutical Scientists. Acta Pharm Hung. 2020; 89: 99-108. [crossref]
• [16] Aponte M, Murru N, Shoukat M. Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective. Front Microbiol. 2020; 11: 562048. [crossref]
• [17] Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers GT. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr. 2010; 140(3): 698S-712S. [crossref]
• [18] Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev. 2009; (4): CD006289. [crossref]
• [19] Gingold-Belfer, R., Levy, S., Layfer, O., Pakanaev, L., Niv, Y., Dickman, R., & Perets, T. T. Use of a Novel Probiotic Formulation to Alleviate Lactose Intolerance Symptoms-a Pilot Study. Probiotics Antimicrob Proteins. 2020; 12(1): 112-118. [crossref]
• [20] Al-Ansari MM, Sahlah SA, AlHumaid L, Ranjit Singh AJ. Probiotic lactobacilli: Can be a remediating supplement for pandemic COVID-19. A review. J King Saud Univ Sci. 2021; 33(2): 101286. [crossref]
• [21] Al-Jumaili AA, Younus MM, Kannan YJA, Nooruldeen ZE, Al-Nuseirat A. Pharmaceutical regulations in Iraq: from medicine approval to postmarketing. East Mediterr Health J. 2021; 27(10): 1007-1015. [CrosRef]
• [22] Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr. 2001; 73(6): 1124S-1130S. [crossref]
• [23] FAO/WHO (2002) Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May. https://www.mhlw.go.jp/file/05-Shingikai-11121000 Iyakushokuhinkyoku-Soumuka/0000197343.pdf
• [24] Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J. 2011; 52(1): 43-46.
• [25] De Vero L, Boniotti MB, Budroni M, et al. Preservation, Characterization and Exploitation of Microbial Biodiversity: The Perspective of the Italian Network of Culture Collections. Microorganisms. 2019; 7(12): 685. [crossref]
• [26] HARTSELL SE. The preservation of bacterial cultures under paraffin oil. Appl Microbiol. 1953; 1(1): 36-41.
• [27] Bowen WS, Gandhapudi SK, Kolb JP, Mitchell TC. Immunopharmacology of lipid A mimetics. Adv Pharmacol. 2013; 66: 81-128. [crossref]
• [28] Lund B, Edlund C. Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin Infect Dis. 2001; 32(9): 1384-1385. [crossref]
• [29] Paoletti C, Foglia G, Princivalli MS, et al. Co-transfer of vanA and aggregation substance genes from Enterococcus faecalis isolates in intra- and interspecies matings. J Antimicrob Chemother. 2007; 59(5): 1005-1009. [crossref]
• [30] Fijan S. Antimicrobial effect of probiotics against common pathogens. Probiotics and prebiotics in human nutrition and health. 2016; 13:191-221. [crossref]
• [31] Venkateswarulu TC, Krupanidhi S, Indira M, Nazneen MD, John BD. Estimation of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of antimicrobial peptides of Saccharomyces boulardii against selected pathogenic strains. Karbala International Journal of Modern Science. 2019; 5(4): 266-269. [crossref]
• [32] Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of Action of Probiotics [published correction appears in Adv Nutr. 2020 Jul 1;11(4):1054]. Adv Nutr. 2019; 10(suppl_1): S49-S66. [crossref]
• [33] Pais P, Almeida V, Yılmaz M, Teixeira MC. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?. J Fungi (Basel). 2020; 6(2): 78. [CrossRef]